Found 82 matching trials
High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD NA The objective of this study is to investigate the feasibility of cervical T...
Show More Location
Phoenix Children's Hospital
Learn More & Join Trial
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers PHASE1 TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion cl...
Show More Location
Arizona Oncology Associates
Learn More & Join Trial
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer PHASE2 The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Show More Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Learn More & Join Trial
Effects of RAS in SZ NA The two main groups of medicated patients with schizophrenia (SZ) are those...
Show More Location
National Taipei University of Nursing and Health Sciences
Learn More & Join Trial
Community Access to Rectal Artesunate for Malaria N/A Many malaria deaths occur in places where people have poor access to preven...
Show More Location
Kinshasa School of Public Health, University of Kinshasa
Learn More & Join Trial
The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment NA Auditory motor-coupling has been shown to induce neural-entrainment that ca...
Show More Location
Toronto Cardiac Rehabilitation Institute
Learn More & Join Trial
Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis PHASE4 This study evaluates prospectively the effects of an anti-angiotensin II re...
Show More Location
"Mater Domini" Hospital
Learn More & Join Trial
Ambulosono Rasagiline Musical Walking Study NA This study will investigate the effects of a contingency-based musical walk...
Show More Location
Pacific Parkinson's Research Centre
Learn More & Join Trial
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB NA The present study will recruit 50 symptomatic non-ischemic cardiomyopathy (...
Show More Status
Active Not Recruiting
Location
Fuwai Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms PHASE1 The goal of Part 1 of this clinical research study is to find the highest t...
Show More Location
MD Anderson Cancer Cente
Learn More & Join Trial